Tag: Novartis
Novartis Shanghai switches from drug research to drug development
Because the Chinese Government is accelerating drug approvals, Novartis needs to dedicate its resources toward getting medicines on China's market. Consequently, the company's Shanghai...
Tencent, Novartis launch online platform for heart patients
Novartis and Tencent jointly announced the launch of an online disease management platform for heart patients. On the platform named AI, it will be...
China approves Novartis multiple sclerosis drug
Novartis won the approval in China for its multiple sclerosis drug Gilenya. Officially, only about 30,000 people in China live with multiple sclerosis (compared...
Novartis boosts drug R&D in China
Novartis plans to expand it's R&D for innovative drugs in China, it's expected that the company will submit 50 drug applications in the country...
Strong Swiss presence at the China International Import Expo
China’s new focus on import products is an excellent opportunity for Swiss businesses; consequently, Switzerland’s presence at the China International Import Expo (CIIE) was...
Novartis profit and sales rise
Novartis stated that its first-quarter profit and sales rose: Net income rose from USD 1.67 billion to USD 2.03 billion and net sales from...
Newest Articles
Renminbi Hub in Switzerland has 13 partner banks
In 2016, the China Construction Bank (CBC) established the Renminbi Hub in Switzerland and since then, is developing cross-border business with the currency in...
